Pixelgen Technologies Launches to Advance Single-Cell Spatial Proteomics
Summary
The launch follows the close of an approximate $6 million seed round, led by , which will support the commercialization next year of the companys groundbreaking Molecular Pixelation technology for spatial analyses of cell surface proteins in 3D. Fredriksson, a serial entrepreneur, was co-founder, CEO and chief science officer at the proteomics firm , where he invented and commercialized the multiplexed Proximity Extension Assay. Fredriksson will lead the executive team including: Co-founder and Chief Data Analysis Officer Alvaro Martinez Barrio Ph.D., is a seasoned computational scientist and former group leader at 10x Genomics Co-founder and Chief Technology Officer is a co-inventor of Molecular Pixelation and previously led development efforts for key product lines at Halo Genomics (now Agilent) and Vanadis (now Perkin Elmer) Chief Business Development Officer , Ph.D., was formerly at Olink and Olink Proteomics, where he was head of business development Director of Sales and Marketing previously held marketing manager and product manager roles at 10x as well as field support managing roles at 10x, Life Technologies, andThe company has assembled a world-class board and team of scientific advisors. Serving on the board, in addition to Fredriksson and Martinez Barrio, are Chair Fredrik Dahl Ph.D., a partner at and a biotech executive and entrepreneur, Bj\xf6rn Algkvist, CEO at Fibonacci Growth Capital AB and Alex Basu Ph.D., Investment Manager at . The company has developed Molecular Pixelation, a DNA-based visualization technology for analyzing cell surface proteins, to gain novel insights into cellular activity that will advance better medicines and diagnostics.